Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Diagnostic Value of 18F-T2 PET/ CT Imaging for Tumors Likely to Express High Levels of CAIX

NCT07557225 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT07557225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07557225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Diagnostic Value of 18F-T2 PET/ CT Imaging for Tumors Likely to Express High Levels of CAIX
Lead sponsor
Peking University First Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
April 27, 2026
Completion date
March 31, 2029
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cervical cancer, cholangiocarcinoma, clear cell renal cell cancer (ccrcc), colorectal cancer, endometrial cancer, head and neck cancer, hepatocellular carcinoma (hcc), non small cell lung cancer, ovarian cancer, pancreatic cancer, small cell lung cancer, urothelial carcinoma (uc), von hippel lindau disease